TFX · Teleflex Incorporated Common Stock
View on chartInsiders & Stakes
| Jason R. Weidman President and CEO | ▲ Buy | Grant | 53,983 Shares held | 6/8/2026 | View profile |
| Liam Kelly Chairman, President & CEO | ▲ Buy | Open Market | 45,267 Shares held | 8/5/2025 | View profile |
| Daniel Logue V CVP, General Counsel & Secty | ▼ Sell | Tax Withholding | 24,653 Shares held | 3/4/2026 | View profile |
| Stuart A. Randle Director | ▲ Buy | Grant | 21,187 Shares held | 6/8/2026 | View profile |
| Thomas E. Powell Executive Vice President & CFO | ▼ Sell | Other | 20,812 Shares held | 4/1/2025 | View profile |
| Cameron P. Hicks Corp. VP & Chief HR Officer | ▼ Sell | Tax Withholding | 19,363 Shares held | 3/4/2026 | View profile |
| John Deren Corp. VP & CAO | ▼ Sell | Tax Withholding | 18,073 Shares held | 3/4/2026 | View profile |
| James Winters Corp VP, Mfg and Supply | ▼ Sell | Tax Withholding | 17,760 Shares held | 3/4/2026 | View profile |
| BABICH GEORGE JR Director | ▲ Buy | Grant | 10,960 Shares held | 5/3/2022 | View profile |
| Stephen K. M.D. Klasko Director | ▲ Buy | Grant | 9,333 Shares held | 5/9/2025 | View profile |
| Andrew A. Krakauer Director | ▲ Buy | Grant | 8,309 Shares held | 5/15/2026 | View profile |
| White Jay VP & Pres, Global Commercial | ▲ Buy | Grant | 7,761 Shares held | 3/4/2025 | View profile |
| Gretchen R. Haggerty Director | ▲ Buy | Grant | 7,395 Shares held | 5/15/2026 | View profile |
| Candace H. Duncan Director | ▲ Buy | Grant | 7,039 Shares held | 5/15/2026 | View profile |
| Jaewon Ryu Director | ▲ Buy | Grant | 4,817 Shares held | 5/15/2026 | View profile |
| John C. Heinmiller Director | ▲ Buy | Grant | 4,176 Shares held | 5/9/2025 | View profile |
| Neena M. Patil EVP & Chief Legal Officer | ▲ Buy | Grant | 3,716 Shares held | 5/15/2026 | View profile |
| Michael J. Tokich Director | ▲ Buy | Grant | 1,090 Shares held | 5/15/2026 | View profile |
| Salmon Sean Director | ▲ Buy | Grant | 674 Shares held | 9/8/2026 | View profile |
Transaction History
| Salmon Sean | ▲ Buy | Grant | 674 | $0 | 9/8/2026 |
| Jason R. Weidman | ▲ Buy | Grant | 53,983 | $0 | 6/8/2026 |
| Stuart A. Randle | ▲ Buy | Grant | 995 | $0 | 6/8/2026 |
| Stuart A. Randle | ▲ Buy | Grant | 4,663 | $0 | 6/8/2026 |
| Stuart A. Randle | ▼ Sell | Tax Withholding | 4,054 | $526K | 6/7/2026 |
| Michael J. Tokich | ▲ Buy | Grant | 1,090 | $0 | 5/15/2026 |
| Jaewon Ryu | ▲ Buy | Grant | 1,090 | $0 | 5/15/2026 |
| Andrew A. Krakauer | ▲ Buy | Grant | 1,090 | $0 | 5/15/2026 |
| Gretchen R. Haggerty | ▲ Buy | Grant | 1,090 | $0 | 5/15/2026 |
| Candace H. Duncan | ▲ Buy | Grant | 1,090 | $0 | 5/15/2026 |
| Neena M. Patil | ▲ Buy | Grant | 1,090 | $0 | 5/15/2026 |
| Stuart A. Randle | ▼ Sell | Tax Withholding | 289 | $38K | 5/9/2026 |
| Cameron P. Hicks | ▼ Sell | Tax Withholding | 98 | $12K | 3/4/2026 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 131 | $16K | 3/4/2026 |
| John Deren | ▼ Sell | Tax Withholding | 229 | $27K | 3/4/2026 |
| James Winters | ▼ Sell | Tax Withholding | 247 | $29K | 3/4/2026 |
| James Winters | ▲ Buy | Grant | 3,262 | $0 | 3/3/2026 |
| James Winters | ▲ Buy | Grant | 9,745 | $0 | 3/3/2026 |
| Daniel Logue V | ▲ Buy | Grant | 6,591 | $0 | 3/3/2026 |
| John Deren | ▲ Buy | Grant | 4,604 | $0 | 3/3/2026 |
| John Deren | ▲ Buy | Grant | 9,180 | $0 | 3/3/2026 |
| Cameron P. Hicks | ▲ Buy | Grant | 2,447 | $0 | 3/3/2026 |
| Cameron P. Hicks | ▲ Buy | Grant | 5,649 | $0 | 3/3/2026 |
| Daniel Logue V | ▲ Buy | Grant | 3,262 | $0 | 3/3/2026 |
| John Deren | ▼ Sell | Tax Withholding | 231 | $28K | 2/28/2026 |
| Cameron P. Hicks | ▼ Sell | Tax Withholding | 396 | $48K | 2/28/2026 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 484 | $59K | 2/28/2026 |
| James Winters | ▼ Sell | Tax Withholding | 661 | $81K | 2/28/2026 |
| Cameron P. Hicks | ▲ Buy | Grant | 352 | $0 | 2/23/2026 |
| Daniel Logue V | ▲ Buy | Grant | 443 | $0 | 2/23/2026 |
| James Winters | ▲ Buy | Grant | 354 | $0 | 2/23/2026 |
| John Deren | ▲ Buy | Grant | 161 | $0 | 2/23/2026 |
| Stuart A. Randle | ▲ Buy | Grant | 12,325 | $0 | 1/13/2026 |
| Gretchen R. Haggerty | ▲ Buy | Open Market | 200 | $23K | 8/6/2025 |
| Gretchen R. Haggerty | ▲ Buy | Open Market | 300 | $34K | 8/6/2025 |
| Andrew A. Krakauer | ▲ Buy | Open Market | 1,000 | $115K | 8/5/2025 |
| Stuart A. Randle | ▲ Buy | Open Market | 1,000 | $116K | 8/5/2025 |
| Liam Kelly | ▲ Buy | Open Market | 1,500 | $173K | 8/5/2025 |
| Jaewon Ryu | ▲ Buy | Open Market | 1,500 | $173K | 8/5/2025 |
| Candace H. Duncan | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| John C. Heinmiller | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| Neena M. Patil | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| Gretchen R. Haggerty | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| Jaewon Ryu | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| Stephen K. M.D. Klasko | ▲ Buy | Grant | 1,357 | $0 | 5/9/2025 |
| Andrew A. Krakauer | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| Stuart A. Randle | ▲ Buy | Grant | 1,051 | $0 | 5/9/2025 |
| Candace H. Duncan | ▲ Buy | Option Exercise | 4,833 | $595K | 5/5/2025 |
| Candace H. Duncan | ▼ Sell | Tax Withholding | 4,705 | $595K | 5/5/2025 |
| Thomas E. Powell | ▼ Sell | Tax Withholding | 468 | $66K | 4/1/2025 |
| Thomas E. Powell | ▼ Sell | Other | 655 | $0 | 4/1/2025 |
| John Deren | ▲ Buy | Grant | 2,676 | $0 | 3/4/2025 |
| Cameron P. Hicks | ▲ Buy | Grant | 1,422 | $0 | 3/4/2025 |
| Liam Kelly | ▲ Buy | Grant | 10,195 | $0 | 3/4/2025 |
| James Winters | ▲ Buy | Grant | 1,896 | $0 | 3/4/2025 |
| White Jay | ▲ Buy | Grant | 1,896 | $0 | 3/4/2025 |
| Thomas E. Powell | ▲ Buy | Grant | 5,664 | $0 | 3/4/2025 |
| Daniel Logue V | ▲ Buy | Grant | 1,896 | $0 | 3/4/2025 |
| James Winters | ▼ Sell | Tax Withholding | 434 | $58K | 3/1/2025 |
| White Jay | ▼ Sell | Tax Withholding | 415 | $55K | 3/1/2025 |
| Thomas E. Powell | ▼ Sell | Tax Withholding | 900 | $119K | 3/1/2025 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 228 | $30K | 3/1/2025 |
| Liam Kelly | ▼ Sell | Tax Withholding | 2,081 | $276K | 3/1/2025 |
| Cameron P. Hicks | ▼ Sell | Tax Withholding | 260 | $35K | 3/1/2025 |
| John Deren | ▼ Sell | Tax Withholding | 157 | $21K | 3/1/2025 |
| Daniel Logue V | ▲ Buy | Grant | 171 | $0 | 2/24/2025 |
| Cameron P. Hicks | ▲ Buy | Grant | 185 | $0 | 2/24/2025 |
| Liam Kelly | ▲ Buy | Grant | 1,317 | $0 | 2/24/2025 |
| White Jay | ▲ Buy | Grant | 305 | $0 | 2/24/2025 |
| James Winters | ▲ Buy | Grant | 195 | $0 | 2/24/2025 |
| John Deren | ▲ Buy | Grant | 92 | $0 | 2/24/2025 |
| Thomas E. Powell | ▲ Buy | Grant | 531 | $0 | 2/24/2025 |
| Daniel Logue V | ▲ Buy | Option Exercise | 1,620 | $196K | 2/20/2025 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 1,195 | $209K | 2/20/2025 |
| Stephen K. M.D. Klasko | ▲ Buy | Option Exercise | 2,674 | $324K | 2/20/2025 |
| Stephen K. M.D. Klasko | ▼ Sell | Tax Withholding | 1,851 | $324K | 2/20/2025 |
| Liam Kelly | ▲ Buy | Option Exercise | 29,084 | $3.5M | 2/19/2025 |
| Liam Kelly | ▲ Buy | Option Exercise | 7,380 | $908K | 2/19/2025 |
| Liam Kelly | ▼ Sell | Tax Withholding | 29,220 | $5.0M | 2/19/2025 |
| John Deren | ▼ Sell | Tax Withholding | 16 | $4K | 8/24/2024 |
| Stuart A. Randle | ▲ Buy | Option Exercise | 2,674 | $324K | 8/16/2024 |
| Stuart A. Randle | ▼ Sell | Open Market | 2,674 | $639K | 8/16/2024 |
| James Winters | ▲ Buy | Grant | 243 | $0 | 6/18/2024 |
| Gretchen R. Haggerty | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| Andrew A. Krakauer | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| Stephen K. M.D. Klasko | ▲ Buy | Grant | 838 | $0 | 5/7/2024 |
| Candace H. Duncan | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| John C. Heinmiller | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| Neena M. Patil | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| Jaewon Ryu | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| Stuart A. Randle | ▲ Buy | Grant | 649 | $0 | 5/7/2024 |
| Cameron P. Hicks | ▲ Buy | Option Exercise | 4,400 | $637K | 3/5/2024 |
| Cameron P. Hicks | ▼ Sell | Open Market | 7,401 | $1.7M | 3/5/2024 |
| Cameron P. Hicks | ▲ Buy | Option Exercise | 3,001 | $363K | 3/5/2024 |
| White Jay | ▼ Sell | Tax Withholding | 239 | $53K | 3/2/2024 |
| James Winters | ▼ Sell | Tax Withholding | 305 | $68K | 3/2/2024 |
| John Deren | ▼ Sell | Tax Withholding | 137 | $31K | 3/2/2024 |
| Liam Kelly | ▼ Sell | Tax Withholding | 1,840 | $410K | 3/2/2024 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 149 | $33K | 3/2/2024 |
| Thomas E. Powell | ▼ Sell | Tax Withholding | 810 | $181K | 3/2/2024 |
| Cameron P. Hicks | ▼ Sell | Tax Withholding | 216 | $49K | 3/2/2024 |
| John Deren | ▲ Buy | Grant | 417 | $0 | 2/27/2024 |
| Thomas E. Powell | ▲ Buy | Grant | 2,373 | $0 | 2/27/2024 |
| Daniel Logue V | ▲ Buy | Grant | 1,317 | $0 | 2/27/2024 |
| White Jay | ▲ Buy | Grant | 1,356 | $0 | 2/27/2024 |
| James Winters | ▲ Buy | Grant | 1,114 | $0 | 2/27/2024 |
| Liam Kelly | ▲ Buy | Grant | 6,787 | $0 | 2/27/2024 |
| Cameron P. Hicks | ▲ Buy | Grant | 988 | $0 | 2/27/2024 |
| Daniel Logue V | ▲ Buy | Option Exercise | 1,525 | $154K | 2/26/2024 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 752 | $172K | 2/26/2024 |
| John Deren | ▲ Buy | Grant | 113 | $0 | 2/19/2024 |
| Thomas E. Powell | ▲ Buy | Grant | 668 | $0 | 2/19/2024 |
| White Jay | ▲ Buy | Grant | 251 | $0 | 2/19/2024 |
| Liam Kelly | ▲ Buy | Grant | 1,856 | $0 | 2/19/2024 |
| Daniel Logue V | ▲ Buy | Grant | 162 | $0 | 2/19/2024 |
| Cameron P. Hicks | ▲ Buy | Grant | 232 | $0 | 2/19/2024 |
| James Winters | ▲ Buy | Grant | 194 | $0 | 2/19/2024 |
| Liam Kelly | ▲ Buy | Option Exercise | 23,175 | $2.3M | 12/27/2023 |
| Liam Kelly | ▼ Sell | Open Market | 23,585 | $5.9M | 12/27/2023 |
| Liam Kelly | ▲ Buy | Option Exercise | 3,081 | $331K | 12/27/2023 |
| Liam Kelly | ▼ Sell | Open Market | 2,671 | $671K | 12/27/2023 |
| Liam Kelly | ▼ Sell | Gift | 5,786 | $0 | 12/21/2023 |
| Liam Kelly | ▼ Sell | Gift | 5,786 | $0 | 12/21/2023 |
| Stephen K. M.D. Klasko | ▲ Buy | Option Exercise | 3,021 | $305K | 12/13/2023 |
| Stephen K. M.D. Klasko | ▼ Sell | Tax Withholding | 1,296 | $306K | 12/13/2023 |
| Thomas E. Powell | ▲ Buy | Option Exercise | 9,339 | $1.1M | 11/29/2023 |
| Thomas E. Powell | ▼ Sell | Open Market | 4,629 | $1.0M | 11/29/2023 |
| Thomas E. Powell | ▲ Buy | Option Exercise | 4,613 | $568K | 11/29/2023 |
| Thomas E. Powell | ▼ Sell | Open Market | 1,866 | $413K | 11/29/2023 |
| Thomas E. Powell | ▼ Sell | Open Market | 5,796 | $1.3M | 11/29/2023 |
| Thomas E. Powell | ▼ Sell | Open Market | 1,661 | $372K | 11/29/2023 |
| Liam Kelly | ▼ Sell | Gift | 5,768 | $0 | 8/9/2023 |
| Liam Kelly | ▼ Sell | Gift | 5,768 | $0 | 8/9/2023 |
| Stuart A. Randle | ▲ Buy | Option Exercise | 3,021 | $305K | 5/10/2023 |
| Stuart A. Randle | ▼ Sell | Open Market | 3,021 | $742K | 5/10/2023 |
| Stephen K. M.D. Klasko | ▲ Buy | Grant | 681 | $0 | 5/9/2023 |
| Andrew A. Krakauer | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| Neena M. Patil | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| Jaewon Ryu | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| Stuart A. Randle | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| John C. Heinmiller | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| Gretchen R. Haggerty | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| Candace H. Duncan | ▲ Buy | Grant | 527 | $0 | 5/9/2023 |
| Thomas E. Powell | ▲ Buy | Grant | 2,357 | $0 | 2/28/2023 |
| John Deren | ▲ Buy | Grant | 414 | $0 | 2/28/2023 |
| Cameron P. Hicks | ▲ Buy | Grant | 906 | $0 | 2/28/2023 |
| Liam Kelly | ▲ Buy | Grant | 5,050 | $0 | 2/28/2023 |
| White Jay | ▲ Buy | Grant | 1,347 | $0 | 2/28/2023 |
| Daniel Logue V | ▲ Buy | Grant | 1,139 | $0 | 2/28/2023 |
| James Winters | ▲ Buy | Grant | 912 | $0 | 2/28/2023 |
| Thomas E. Powell | ▼ Sell | Tax Withholding | 542 | $127K | 2/25/2023 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 40 | $9K | 2/25/2023 |
| Liam Kelly | ▼ Sell | Tax Withholding | 1,025 | $241K | 2/25/2023 |
| Cameron P. Hicks | ▼ Sell | Tax Withholding | 134 | $32K | 2/25/2023 |
| John Deren | ▼ Sell | Tax Withholding | 88 | $21K | 2/25/2023 |
| White Jay | ▼ Sell | Tax Withholding | 135 | $32K | 2/25/2023 |
| James Winters | ▼ Sell | Tax Withholding | 173 | $41K | 2/25/2023 |
| Stephen K. M.D. Klasko | ▲ Buy | Option Exercise | 3,014 | $237K | 1/27/2023 |
| Stephen K. M.D. Klasko | ▼ Sell | Tax Withholding | 967 | $237K | 1/27/2023 |
| Liam Kelly | ▲ Buy | Option Exercise | 6,040 | $475K | 1/11/2023 |
| Liam Kelly | ▼ Sell | Tax Withholding | 3,622 | $940K | 1/11/2023 |
| Liam Kelly | ▲ Buy | Option Exercise | 3,579 | $294K | 1/11/2023 |
| Liam Kelly | ▼ Sell | Tax Withholding | 2,173 | $564K | 1/11/2023 |
| Liam Kelly | ▲ Buy | Option Exercise | 16,343 | $1.3M | 12/30/2022 |
| Liam Kelly | ▼ Sell | Open Market | 16,340 | $4.1M | 12/30/2022 |
| Liam Kelly | ▼ Sell | Open Market | 3 | $753 | 12/30/2022 |
| Stuart A. Randle | ▲ Buy | Option Exercise | 3,014 | $237K | 6/7/2022 |
| Stuart A. Randle | ▼ Sell | Open Market | 3,014 | $854K | 6/7/2022 |
| BABICH GEORGE JR | ▲ Buy | Grant | 520 | $0 | 5/3/2022 |
| Candace H. Duncan | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| Gretchen R. Haggerty | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| Neena M. Patil | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| Stuart A. Randle | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| John C. Heinmiller | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| Stephen K. M.D. Klasko | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| Andrew A. Krakauer | ▲ Buy | Grant | 399 | $0 | 5/3/2022 |
| Liam Kelly | ▲ Buy | Grant | 4,766 | $0 | 3/1/2022 |
| James Winters | ▲ Buy | Grant | 635 | $0 | 3/1/2022 |
| White Jay | ▲ Buy | Grant | 993 | $0 | 3/1/2022 |
| Daniel Logue V | ▲ Buy | Grant | 556 | $0 | 3/1/2022 |
| Thomas E. Powell | ▲ Buy | Grant | 1,728 | $0 | 3/1/2022 |
| Cameron P. Hicks | ▲ Buy | Grant | 600 | $0 | 3/1/2022 |
| John Deren | ▲ Buy | Grant | 298 | $0 | 3/1/2022 |
| White Jay | ▼ Sell | Tax Withholding | 132 | $45K | 2/28/2022 |
| Liam Kelly | ▼ Sell | Tax Withholding | 1,244 | $427K | 2/28/2022 |
| Cameron P. Hicks | ▼ Sell | Tax Withholding | 171 | $59K | 2/28/2022 |
| Daniel Logue V | ▼ Sell | Tax Withholding | 59 | $20K | 2/28/2022 |
| Thomas E. Powell | ▼ Sell | Tax Withholding | 728 | $250K | 2/28/2022 |
| John Deren | ▼ Sell | Tax Withholding | 121 | $42K | 2/28/2022 |
| James Winters | ▼ Sell | Tax Withholding | 223 | $76K | 2/28/2022 |
| White Jay | ▲ Buy | Grant | 4 | $0 | 2/28/2022 |
| John Deren | ▲ Buy | Grant | 3 | $0 | 2/28/2022 |
| Thomas E. Powell | ▲ Buy | Grant | 16 | $0 | 2/28/2022 |
| Liam Kelly | ▲ Buy | Grant | 33 | $0 | 2/28/2022 |
| Daniel Logue V | ▲ Buy | Grant | 2 | $0 | 2/28/2022 |
| Cameron P. Hicks | ▲ Buy | Grant | 5 | $0 | 2/28/2022 |
| Liam Kelly | ▲ Buy | Option Exercise | 2,276 | $136K | 12/27/2021 |
| Liam Kelly | ▲ Buy | Option Exercise | 6,711 | $402K | 12/27/2021 |
| Liam Kelly | ▼ Sell | Open Market | 8,987 | $3.0M | 12/27/2021 |
| Andrew A. Krakauer | ▲ Buy | Open Market | 500 | $154K | 11/30/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Teleflex Shares Lag Peers Amid Q2 Earnings and Value Debate
Teleflex (TFX) recently released its Q2 2026 earnings call transcript, which has fueled ongoing discussions about its valuation relative to peers like Sonovion. While some analysts highlight its status as a value stock, others have flagged concerns within the broader healthcare sector. The stock is currently trading near its 52-week low, reflecting a cautious market sentiment despite an average analyst target that remains significantly higher than the current price.
Teleflex Shares Lag Peers Amid Q2 Earnings and Value Debate. Teleflex (TFX) recently released its Q2 2026 earnings call transcript, which has fueled ongoing discussions about its valuation relative to peers like Sonovion. While some analysts highlight its status as a value stock, others have flagged concerns within the broader healthcare sector. The stock is currently trading near its 52-week low, reflecting a cautious market sentiment despite an average analyst target that remains significantly higher than the current price.